For the quarter ending 2025-09-30, KLTOW has $10,073,144 in assets. $145,891 in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 7,348,034 | - | ||
| Prepaid expenses | 86,303 | 115,386 | ||
| Cash and cash equivalents | - | 8,430,946 | ||
| Subscriptions receivable | 339,253 | - | ||
| Total current assets | 7,773,590 | 8,546,332 | ||
| Licenses | 2,251,134 | 2,251,134 | ||
| Patents | 48,420 | 48,420 | ||
| Total other assets | 2,299,554 | 2,299,554 | ||
| Total assets | 10,073,144 | 10,845,886 | ||
| Notes payable to related parties-Related Party | - | 0 | ||
| Notes payable | - | 0 | ||
| Accounts payable | 34,905 | 12,631 | ||
| Accrued expenses | 57,986 | 50,331 | ||
| Total current liabilities | 92,891 | 62,962 | ||
| Warrant liability | 53,000 | 132,447 | ||
| Total liabilities | 145,891 | 195,409 | ||
| Common stock, par value 0.0001, 1,000,000,000 shares authorized 70,334,792 and 27,080,915 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 7,033 | 5,270 | ||
| Additional paid-in capital | 29,705,817 | 27,535,219 | ||
| Accumulated deficit | -19,785,597 | -16,890,012 | ||
| Total stockholders equity | 9,927,253 | 10,650,477 | ||
| Total liabilities and stockholders equity | 10,073,144 | 10,845,886 | ||
Klotho Neurosciences, Inc. (KLTOW)
Klotho Neurosciences, Inc. (KLTOW)